Stockreport

BRIEF-Hemispherx Biopharma Reports Q1 Operating Loss Per Share Of $0.70 [Reuters]

HEMISPHERX BIOPHARMA  (HEB) 
NASDAQ:AMEX Investor Relations: hemispherx.net/mobile/investor-relations.php
PDF BRIEF-Hemispherx Biopharma Reports Q1 Operating Loss Per Share Of $0.70 | Reuters Reuters Staff 1 Min Read May 16 (Reuters) - Hemispherx Biopharma Inc: * HEMISPHERX BIOP [Read more]